Madrigal Pharmaceuticals (MDGL) total debt

Total debt · fiscal 2025
$347.63M

Madrigal Pharmaceuticals (MDGL) carried total debt of $347.63M at the end of fiscal 2025 (December 31, 2025). That is 190.7% higher than the $119.57M of fiscal 2024. Figures as of 18 Nov 2026, 03:02 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$347.63M
Change on fiscal 2024
+190.7%
Highest on record
$347.63Mfiscal 2025
Lowest on record
$0.00fiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Madrigal Pharmaceuticals total debt, in more detail

Across the 5 fiscal years on record (2021–2025), the highest was $347.63M in fiscal 2025 and the lowest $0.00 in fiscal 2021.

Total debt was 0.6× shareholders' equity at the end of fiscal 2025.

History · 5 fiscal years

Total debt by fiscal year

Madrigal Pharmaceuticals total debt, year by year

Madrigal Pharmaceuticals (MDGL) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$347.63M 190.7% up0.6×
2024$119.57M 2.0% up0.2×
2023$117.19M 134.9% up0.3×
2022$49.89M—0.3×
2021$0.00—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Madrigal Pharmaceuticals and comparable companies
CompanyTotal debtFiscal year
Qiagen QGEN$1.81B2025
Insulet PODD$949.20M2025
Bruker BRKR$2.04B2025
Globus Medical GMED$118.66M2025
Madrigal Pharmaceuticals MDGL$347.63M2025
Henry Schein HSIC$3.44B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MDGL

Madrigal Pharmaceuticals, figure by figure

Madrigal Pharmaceuticals (MDGL) overview: price, valuation and scorecardAll health care companies by market value

Madrigal Pharmaceuticals total debt: questions and answers

How much debt does Madrigal Pharmaceuticals have?

Madrigal Pharmaceuticals (MDGL) carried total debt of $347.63M at the end of fiscal 2025 (December 31, 2025). That is 190.7% higher than the $119.57M of fiscal 2024.

What are the highest and lowest total debt figures on record for Madrigal Pharmaceuticals?

Across the 5 fiscal years on record (2021–2025), the highest was $347.63M in fiscal 2025 and the lowest $0.00 in fiscal 2021.

How does Madrigal Pharmaceuticals's debt compare with its equity?

Total debt was 0.6× shareholders' equity at the end of fiscal 2025.

How is Madrigal Pharmaceuticals's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Madrigal Pharmaceuticals (MDGL) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/MDGL/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.